1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Hepatitis B Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Hepatitis B Vaccine 1.2.3 Anti-viral Drugs 1.3 Market by Application 1.3.1 Global Hepatitis B Therapeutics Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital Pharmacies 1.3.3 Retail Pharmacies 1.3.4 Online Pharmacies 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Hepatitis B Therapeutics Market Perspective (2016-2027) 2.2 Hepatitis B Therapeutics Growth Trends by Regions 2.2.1 Hepatitis B Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Hepatitis B Therapeutics Historic Market Share by Regions (2016-2021) 2.2.3 Hepatitis B Therapeutics Forecasted Market Size by Regions (2022-2027) 2.3 Hepatitis B Therapeutics Industry Dynamic 2.3.1 Hepatitis B Therapeutics Market Trends 2.3.2 Hepatitis B Therapeutics Market Drivers 2.3.3 Hepatitis B Therapeutics Market Challenges 2.3.4 Hepatitis B Therapeutics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Hepatitis B Therapeutics Players by Revenue 3.1.1 Global Top Hepatitis B Therapeutics Players by Revenue (2016-2021) 3.1.2 Global Hepatitis B Therapeutics Revenue Market Share by Players (2016-2021) 3.2 Global Hepatitis B Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Hepatitis B Therapeutics Revenue 3.4 Global Hepatitis B Therapeutics Market Concentration Ratio 3.4.1 Global Hepatitis B Therapeutics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Hepatitis B Therapeutics Revenue in 2020 3.5 Hepatitis B Therapeutics Key Players Head office and Area Served 3.6 Key Players Hepatitis B Therapeutics Product Solution and Service 3.7 Date of Enter into Hepatitis B Therapeutics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Hepatitis B Therapeutics Breakdown Data by Type 4.1 Global Hepatitis B Therapeutics Historic Market Size by Type (2016-2021) 4.2 Global Hepatitis B Therapeutics Forecasted Market Size by Type (2022-2027) 5 Hepatitis B Therapeutics Breakdown Data by Application 5.1 Global Hepatitis B Therapeutics Historic Market Size by Application (2016-2021) 5.2 Global Hepatitis B Therapeutics Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Hepatitis B Therapeutics Market Size (2016-2027) 6.2 North America Hepatitis B Therapeutics Market Size by Type 6.2.1 North America Hepatitis B Therapeutics Market Size by Type (2016-2021) 6.2.2 North America Hepatitis B Therapeutics Market Size by Type (2022-2027) 6.2.3 North America Hepatitis B Therapeutics Market Size by Type (2016-2027) 6.3 North America Hepatitis B Therapeutics Market Size by Application 6.3.1 North America Hepatitis B Therapeutics Market Size by Application (2016-2021) 6.3.2 North America Hepatitis B Therapeutics Market Size by Application (2022-2027) 6.3.3 North America Hepatitis B Therapeutics Market Size by Application (2016-2027) 6.4 North America Hepatitis B Therapeutics Market Size by Country 6.4.1 North America Hepatitis B Therapeutics Market Size by Country (2016-2021) 6.4.2 North America Hepatitis B Therapeutics Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Hepatitis B Therapeutics Market Size (2016-2027) 7.2 Europe Hepatitis B Therapeutics Market Size by Type 7.2.1 Europe Hepatitis B Therapeutics Market Size by Type (2016-2021) 7.2.2 Europe Hepatitis B Therapeutics Market Size by Type (2022-2027) 7.2.3 Europe Hepatitis B Therapeutics Market Size by Type (2016-2027) 7.3 Europe Hepatitis B Therapeutics Market Size by Application 7.3.1 Europe Hepatitis B Therapeutics Market Size by Application (2016-2021) 7.3.2 Europe Hepatitis B Therapeutics Market Size by Application (2022-2027) 7.3.3 Europe Hepatitis B Therapeutics Market Size by Application (2016-2027) 7.4 Europe Hepatitis B Therapeutics Market Size by Country 7.4.1 Europe Hepatitis B Therapeutics Market Size by Country (2016-2021) 7.4.2 Europe Hepatitis B Therapeutics Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Hepatitis B Therapeutics Market Size (2016-2027) 8.2 Asia-Pacific Hepatitis B Therapeutics Market Size by Type 8.2.1 Asia-Pacific Hepatitis B Therapeutics Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Hepatitis B Therapeutics Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Hepatitis B Therapeutics Market Size by Type (2016-2027) 8.3 Asia-Pacific Hepatitis B Therapeutics Market Size by Application 8.3.1 Asia-Pacific Hepatitis B Therapeutics Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Hepatitis B Therapeutics Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Hepatitis B Therapeutics Market Size by Application (2016-2027) 8.4 Asia-Pacific Hepatitis B Therapeutics Market Size by Region 8.4.1 Asia-Pacific Hepatitis B Therapeutics Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Hepatitis B Therapeutics Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Hepatitis B Therapeutics Market Size (2016-2027) 9.2 Latin America Hepatitis B Therapeutics Market Size by Type 9.2.1 Latin America Hepatitis B Therapeutics Market Size by Type (2016-2021) 9.2.2 Latin America Hepatitis B Therapeutics Market Size by Type (2022-2027) 9.2.3 Latin America Hepatitis B Therapeutics Market Size by Type (2016-2027) 9.3 Latin America Hepatitis B Therapeutics Market Size by Application 9.3.1 Latin America Hepatitis B Therapeutics Market Size by Application (2016-2021) 9.3.2 Latin America Hepatitis B Therapeutics Market Size by Application (2022-2027) 9.3.3 Latin America Hepatitis B Therapeutics Market Size by Application (2016-2027) 9.4 Latin America Hepatitis B Therapeutics Market Size by Country 9.4.1 Latin America Hepatitis B Therapeutics Market Size by Country (2016-2021) 9.4.2 Latin America Hepatitis B Therapeutics Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Hepatitis B Therapeutics Market Size (2016-2027) 10.2 Middle East & Africa Hepatitis B Therapeutics Market Size by Type 10.2.1 Middle East & Africa Hepatitis B Therapeutics Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Hepatitis B Therapeutics Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Hepatitis B Therapeutics Market Size by Type (2016-2027) 10.3 Middle East & Africa Hepatitis B Therapeutics Market Size by Application 10.3.1 Middle East & Africa Hepatitis B Therapeutics Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Hepatitis B Therapeutics Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Hepatitis B Therapeutics Market Size by Application (2016-2027) 10.4 Middle East & Africa Hepatitis B Therapeutics Market Size by Country 10.4.1 Middle East & Africa Hepatitis B Therapeutics Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Hepatitis B Therapeutics Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 GlaxoSmithKline 11.1.1 GlaxoSmithKline Company Details 11.1.2 GlaxoSmithKline Business Overview 11.1.3 GlaxoSmithKline Hepatitis B Therapeutics Introduction 11.1.4 GlaxoSmithKline Revenue in Hepatitis B Therapeutics Business (2016-2021) 11.1.5 GlaxoSmithKline Recent Development 11.2 Bristol-Myers Squibb 11.2.1 Bristol-Myers Squibb Company Details 11.2.2 Bristol-Myers Squibb Business Overview 11.2.3 Bristol-Myers Squibb Hepatitis B Therapeutics Introduction 11.2.4 Bristol-Myers Squibb Revenue in Hepatitis B Therapeutics Business (2016-2021) 11.2.5 Bristol-Myers Squibb Recent Development 11.3 Novira Therapeutics 11.3.1 Novira Therapeutics Company Details 11.3.2 Novira Therapeutics Business Overview 11.3.3 Novira Therapeutics Hepatitis B Therapeutics Introduction 11.3.4 Novira Therapeutics Revenue in Hepatitis B Therapeutics Business (2016-2021) 11.3.5 Novira Therapeutics Recent Development 11.4 Johnson & Johnson 11.4.1 Johnson & Johnson Company Details 11.4.2 Johnson & Johnson Business Overview 11.4.3 Johnson & Johnson Hepatitis B Therapeutics Introduction 11.4.4 Johnson & Johnson Revenue in Hepatitis B Therapeutics Business (2016-2021) 11.4.5 Johnson & Johnson Recent Development 11.5 Abivax 11.5.1 Abivax Company Details 11.5.2 Abivax Business Overview 11.5.3 Abivax Hepatitis B Therapeutics Introduction 11.5.4 Abivax Revenue in Hepatitis B Therapeutics Business (2016-2021) 11.5.5 Abivax Recent Development 11.6 F. Hoffmann- La Roche 11.6.1 F. Hoffmann- La Roche Company Details 11.6.2 F. Hoffmann- La Roche Business Overview 11.6.3 F. Hoffmann- La Roche Hepatitis B Therapeutics Introduction 11.6.4 F. Hoffmann- La Roche Revenue in Hepatitis B Therapeutics Business (2016-2021) 11.6.5 F. Hoffmann- La Roche Recent Development 11.7 Novartis 11.7.1 Novartis Company Details 11.7.2 Novartis Business Overview 11.7.3 Novartis Hepatitis B Therapeutics Introduction 11.7.4 Novartis Revenue in Hepatitis B Therapeutics Business (2016-2021) 11.7.5 Novartis Recent Development 11.8 Merck 11.8.1 Merck Company Details 11.8.2 Merck Business Overview 11.8.3 Merck Hepatitis B Therapeutics Introduction 11.8.4 Merck Revenue in Hepatitis B Therapeutics Business (2016-2021) 11.8.5 Merck Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Hepatitis B Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Hepatitis B Vaccine Table 3. Key Players of Anti-viral Drugs Table 4. Global Hepatitis B Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Hepatitis B Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Hepatitis B Therapeutics Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Hepatitis B Therapeutics Market Share by Regions (2016-2021) Table 8. Global Hepatitis B Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Hepatitis B Therapeutics Market Share by Regions (2022-2027) Table 10. Hepatitis B Therapeutics Market Trends Table 11. Hepatitis B Therapeutics Market Drivers Table 12. Hepatitis B Therapeutics Market Challenges Table 13. Hepatitis B Therapeutics Market Restraints Table 14. Global Hepatitis B Therapeutics Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Hepatitis B Therapeutics Market Share by Players (2016-2021) Table 16. Global Top Hepatitis B Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis B Therapeutics as of 2020) Table 17. Ranking of Global Top Hepatitis B Therapeutics Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Hepatitis B Therapeutics Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Hepatitis B Therapeutics Product Solution and Service Table 21. Date of Enter into Hepatitis B Therapeutics Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Hepatitis B Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 24. Global Hepatitis B Therapeutics Revenue Market Share by Type (2016-2021) Table 25. Global Hepatitis B Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Hepatitis B Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Hepatitis B Therapeutics Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Hepatitis B Therapeutics Revenue Market Share by Application (2016-2021) Table 29. Global Hepatitis B Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Hepatitis B Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Hepatitis B Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 32. North America Hepatitis B Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Hepatitis B Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 34. North America Hepatitis B Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Hepatitis B Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Hepatitis B Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Hepatitis B Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Hepatitis B Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Hepatitis B Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Hepatitis B Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Hepatitis B Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Hepatitis B Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Hepatitis B Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Hepatitis B Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Hepatitis B Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Hepatitis B Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Hepatitis B Therapeutics Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Hepatitis B Therapeutics Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Hepatitis B Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Hepatitis B Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Hepatitis B Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Hepatitis B Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Hepatitis B Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Hepatitis B Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Hepatitis B Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Hepatitis B Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Hepatitis B Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Hepatitis B Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Hepatitis B Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Hepatitis B Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 61. GlaxoSmithKline Company Details Table 62. GlaxoSmithKline Business Overview Table 63. GlaxoSmithKline Hepatitis B Therapeutics Product Table 64. GlaxoSmithKline Revenue in Hepatitis B Therapeutics Business (2016-2021) & (US$ Million) Table 65. GlaxoSmithKline Recent Development Table 66. Bristol-Myers Squibb Company Details Table 67. Bristol-Myers Squibb Business Overview Table 68. Bristol-Myers Squibb Hepatitis B Therapeutics Product Table 69. Bristol-Myers Squibb Revenue in Hepatitis B Therapeutics Business (2016-2021) & (US$ Million) Table 70. Bristol-Myers Squibb Recent Development Table 71. Novira Therapeutics Company Details Table 72. Novira Therapeutics Business Overview Table 73. Novira Therapeutics Hepatitis B Therapeutics Product Table 74. Novira Therapeutics Revenue in Hepatitis B Therapeutics Business (2016-2021) & (US$ Million) Table 75. Novira Therapeutics Recent Development Table 76. Johnson & Johnson Company Details Table 77. Johnson & Johnson Business Overview Table 78. Johnson & Johnson Hepatitis B Therapeutics Product Table 79. Johnson & Johnson Revenue in Hepatitis B Therapeutics Business (2016-2021) & (US$ Million) Table 80. Johnson & Johnson Recent Development Table 81. Abivax Company Details Table 82. Abivax Business Overview Table 83. Abivax Hepatitis B Therapeutics Product Table 84. Abivax Revenue in Hepatitis B Therapeutics Business (2016-2021) & (US$ Million) Table 85. Abivax Recent Development Table 86. F. Hoffmann- La Roche Company Details Table 87. F. Hoffmann- La Roche Business Overview Table 88. F. Hoffmann- La Roche Hepatitis B Therapeutics Product Table 89. F. Hoffmann- La Roche Revenue in Hepatitis B Therapeutics Business (2016-2021) & (US$ Million) Table 90. F. Hoffmann- La Roche Recent Development Table 91. Novartis Company Details Table 92. Novartis Business Overview Table 93. Novartis Hepatitis B Therapeutics Product Table 94. Novartis Revenue in Hepatitis B Therapeutics Business (2016-2021) & (US$ Million) Table 95. Novartis Recent Development Table 96. Merck Company Details Table 97. Merck Business Overview Table 98. Merck Revenue in Hepatitis B Therapeutics Business (2016-2021) & (US$ Million) Table 99. Merck Recent Development Table 100. Research Programs/Design for This Report Table 101. Key Data Information from Secondary Sources Table 102. Key Data Information from Primary Sources List of Figures Figure 1. Global Hepatitis B Therapeutics Market Share by Type: 2020 VS 2027 Figure 2. Hepatitis B Vaccine Features Figure 3. Anti-viral Drugs Features Figure 4. Global Hepatitis B Therapeutics Market Share by Application: 2020 VS 2027 Figure 5. Hospital Pharmacies Case Studies Figure 6. Retail Pharmacies Case Studies Figure 7. Online Pharmacies Case Studies Figure 8. Hepatitis B Therapeutics Report Years Considered Figure 9. Global Hepatitis B Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Hepatitis B Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Hepatitis B Therapeutics Market Share by Regions: 2020 VS 2027 Figure 12. Global Hepatitis B Therapeutics Market Share by Regions (2022-2027) Figure 13. Global Hepatitis B Therapeutics Market Share by Players in 2020 Figure 14. Global Top Hepatitis B Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis B Therapeutics as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Hepatitis B Therapeutics Revenue in 2020 Figure 16. Global Hepatitis B Therapeutics Revenue Market Share by Type (2016-2021) Figure 17. Global Hepatitis B Therapeutics Revenue Market Share by Type (2022-2027) Figure 18. North America Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Hepatitis B Therapeutics Market Share by Type (2016-2027) Figure 20. North America Hepatitis B Therapeutics Market Share by Application (2016-2027) Figure 21. North America Hepatitis B Therapeutics Market Share by Country (2016-2027) Figure 22. United States Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Hepatitis B Therapeutics Market Share by Type (2016-2027) Figure 26. Europe Hepatitis B Therapeutics Market Share by Application (2016-2027) Figure 27. Europe Hepatitis B Therapeutics Market Share by Country (2016-2027) Figure 28. Germany Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Hepatitis B Therapeutics Market Share by Type (2016-2027) Figure 36. Asia-Pacific Hepatitis B Therapeutics Market Share by Application (2016-2027) Figure 37. Asia-Pacific Hepatitis B Therapeutics Market Share by Region (2016-2027) Figure 38. China Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Hepatitis B Therapeutics Market Share by Type (2016-2027) Figure 46. Latin America Hepatitis B Therapeutics Market Share by Application (2016-2027) Figure 47. Latin America Hepatitis B Therapeutics Market Share by Country (2016-2027) Figure 48. Mexico Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Hepatitis B Therapeutics Market Share by Type (2016-2027) Figure 52. Middle East & Africa Hepatitis B Therapeutics Market Share by Application (2016-2027) Figure 53. Middle East & Africa Hepatitis B Therapeutics Market Share by Country (2016-2027) Figure 54. Turkey Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Hepatitis B Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. GlaxoSmithKline Revenue Growth Rate in Hepatitis B Therapeutics Business (2016-2021) Figure 58. Bristol-Myers Squibb Revenue Growth Rate in Hepatitis B Therapeutics Business (2016-2021) Figure 59. Novira Therapeutics Revenue Growth Rate in Hepatitis B Therapeutics Business (2016-2021) Figure 60. Johnson & Johnson Revenue Growth Rate in Hepatitis B Therapeutics Business (2016-2021) Figure 61. Abivax Revenue Growth Rate in Hepatitis B Therapeutics Business (2016-2021) Figure 62. F. Hoffmann- La Roche Revenue Growth Rate in Hepatitis B Therapeutics Business (2016-2021) Figure 63. Novartis Revenue Growth Rate in Hepatitis B Therapeutics Business (2016-2021) Figure 64. Merck Revenue Growth Rate in Hepatitis B Therapeutics Business (2016-2021) Figure 65. Bottom-up and Top-down Approaches for This Report Figure 66. Data Triangulation Figure 67. Key Executives Interviewed

GlaxoSmithKline Bristol-Myers Squibb Novira Therapeutics Johnson & Johnson Abivax F. Hoffmann- La Roche Novartis Merck